FDA Panel Unhappy With Novel OA Pain Drug Latest setback for troubled osteoarthritis biologic Mar 25, 2021
Benzene Found in Multiple Hand Sanitizer Brands Known human carcinogen can be absorbed through the skin Mar 25, 2021
Op-Ed: Blood Cancer Patients Need More COVID Vax Answers Patients are left wondering, "will I be protected?" Mar 24, 2021
Banned Stimulants Again Found in Supplements Researchers question FDA's commitment to enforcement Mar 23, 2021
Op-Ed: Now Isn't the Time to Ignore the Opioid Crisis Swift federal action can remove barriers to life-saving treatment Mar 06, 2021
FDA Warns Mercola for Selling Bogus COVID Treatments Controversial physician in trouble for claims about vitamin C, vitamin D, and quercetin products Mar 05, 2021
J&J COVID Vaccine Gets Green Light from FDA Panel No dissent on question of whether benefits outweigh risks Feb 26, 2021
Device to Prevent Athletes' Brain Injury Wins FDA Nod Low-tech neck collar keeps brain from "sloshing" during moderate impacts Feb 26, 2021
FDA Advisors Pan Drug-Coated Balloon for Lower-Leg Ischemia Panel members cite muddy efficacy data Feb 18, 2021
First Drug Approved for Some HFpEF FDA doesn't set hard limits on ejection fraction in expanded indication Feb 16, 2021
New Drug OK'd for Chemo-Induced Myelosuppression in SCLC CDK4/6 inhibitor cut the risk for severe neutropenia in small-cell lung cancer patients Feb 13, 2021
First Immunotherapy Approved for Basal Cell Carcinoma Objective responses in 27% of previously treated patients who received cemiplimab Feb 10, 2021
FDA Panel Slows the Roll for Pembrolizumab in Breast Cancer Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
Has Pembrolizumab Finally Met an Indication FDA Doesn't Like? Agency staff skeptical of data in early breast cancer Feb 08, 2021
HCP Busted for Selling Fake Stem Cell Therapy Assistant physician and Missouri state legislator indicted for wire fraud, other crimes Feb 04, 2021
Combined Cath Approach No Match for Surgery for Aortic Stenosis, CAD Pacemakers increasingly an issue in TAVR plus PCI Jan 30, 2021
Will Recovering COVID-19 Patients Soon Be Walking Around on ECMO? This year's winner of the STS "Shark Tank" session Jan 30, 2021
JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemo News, features, and commentary about cancer-related issues Jan 21, 2021
Feds Crack Down on Vitamin D COVID 'Cures' Georgia-based companies ordered to stop sales after national recall, DOJ says Jan 11, 2021
Promising Peanut Allergy Treatments Hit Snags in 2020 COVID-19 interrupts Palforzia rollout; FDA slams door on competitor's patch therapy Jan 03, 2021
Metformin Recalls Ballooned in 2020 Last addition to the list in November brought number to 254 products recalled Dec 29, 2020
How Do We Inject Confidence Into Vaccine Hesitant Americans? "We need to really up our game in terms of communicating," says Peter Hotez, MD, PhD Dec 23, 2020 podcast
'We Want Them Infected'; Extra Vax Doses; Tom Cruise, Distancing Enforcer A daily roundup of news on COVID-19 and the rest of medicine Dec 17, 2020
FDA Panel Backs Entresto, Spironolactone for Broader HF Use But committee stops short of advocating categorical approval for HFpEF Dec 16, 2020
FDA OK's First-Ever Synthetic Implant for ACL Tears Bioresorbable device fills gap between torn ligament ends Dec 16, 2020
FDA Review Gives Rosy Outlook for What Could Be First HFpEF Drugs Advisory committee weigh unusual moves for Entresto and spironolactone Dec 14, 2020
Saxenda OK'd for Teens with Obesity Liraglutide label now includes adolescents as young as 12 Dec 07, 2020
FDA OKs 'Game Changer' Radiotracer for Prostate Cancer PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
Colchicine Approval Took a Huge Toll on CMS As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
FDA OKs JAK Inhibitor and Remdesivir Combo for Severe COVID-19 EUA first for drug that acts on inflammation pathway, agency says Nov 19, 2020
Omega-3s Humbled by Corn Oil Placebo in Two Trials Implications for REDUCE-IT's icosapent ethyl unclear Nov 15, 2020
Omecamtiv's Benefit in HFrEF Trial Gets Lukewarm Reception Can novel oral drug stand out from the crowd? Nov 13, 2020
Doc Convicted for Needless Surgeries; COVID Test Racket; Biden's FDA Chief The past week in healthcare investigations Nov 11, 2020
Presbyopia Device Fails to Win Over FDA Panel Data suggest modest benefit and risk for scleral implant system Nov 10, 2020
Brilinta Wins Indication in Recurrent Stroke Prevention FDA approval based on THALES give the drug a foothold beyond CVD Nov 06, 2020
FDA Warns Against NSAIDs in Pregnancy After 20 Weeks Risk of kidney complications and low amniotic fluids may jeopardize fetus Oct 15, 2020
Reddit Users Self-Medicating With CBD for Treatable Conditions Patients may be substituting cannabis compound for evidence-based care Oct 15, 2020
FDA Panel: Some Risk OK for Olanzapine Combo With Less Weight Gain 11-6 majority said labeling was sufficient to mitigate dangers from opioid antagonist component Oct 09, 2020
